von Deimling

Jul 2, 2024 | academic.oup.com | von Deimling |CHU Lille |Del Giudice |Charité Universitätsmedizin Berlin

The standard treatment for patients with localized or locally advanced muscle-invasive bladder cancer (MIBC) is radical cystectomy (RC) with pelvic lymph node dissection,1 preceded by cisplatin-based neoadjuvant chemotherapy (NAC).2 Meta-analyses of randomized trials have demonstrated an absolute overall survival improvement by 5%-8% at 5 years for cisplatin-based NAC followed by RC in comparison with RC alone.3 However, cisplatin-ineligibility in MIBC is caused by multiple factors, such as...

Sep 16, 2023 | paperity.org | von Deimling

Acta Neuropathologica Communications, Aug 2023 This is a preview of a remote PDF: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-023-01630-w Tauziède-Espariat, Arnault, Masliah-Planchon, Julien, Andrianteranagna, Mamy, Sievers, Philipp, Sahm, Felix, von Deimling, Andreas, Hasty, Lauren, Delattre, Olivier, Beccaria, Kévin, Métais, Alice, Chrétien, Fabrice, Varlet, Pascale, Bourdeaut, Franck.

Jul 26, 2023 | aacrjournals.org | von Deimling

Citation Tobias KesslerDaniel SchrimpfLaura DoernerLing HaiLeon D. KaulenJakob ItoMartin van den BentMartin TaphoornAlba A. BrandesAhmed IdbaihJulien DômontPaul M. ClementMario CamponeMartin BendszusAndreas von DeimlingFelix SahmMichael PlattenWolfgang WickAntje Wick; Prognostic markers of DNA methylation and NGS sequencing in progressive glioblastoma from the EORTC-26101 trial.